ALS drug will be pulled from US market after study showed patients didn't benefit

  • 📰 10TV
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 51%

Sverige Nyheter Nyheter

Sverige Senaste nytt,Sverige Rubriker

The grant was awarded by the U.S. Department of Transportation.

The drug’s failure is a major disappointment for ALS patients and advocates who pressed the FDA to approve it back in 2022.said Thursday it will pull the medicine from the market, acknowledging it didn't help patients with the deadly neurological condition.

“While this is a difficult moment for the ALS community, we reached this path forward in partnership with the stakeholders who will be impacted and in line with our steadfast commitment to people living with ALS," company co-founders said in a statement. Patients already taking the therapy who wish to continue will be able to enroll in a program to receive it for free.

 

Tack för din kommentar. Din kommentar kommer att publiceras efter att ha granskats.
Vi har sammanfattat den här nyheten så att du kan läsa den snabbt. Om du är intresserad av nyheterna kan du läsa hela texten här. Läs mer:

 /  🏆 560. in SE

Sverige Senaste nytt, Sverige Rubriker

Similar News:Du kan också läsa nyheter som liknar den här som vi har samlat in från andra nyhetskällor.

10 Westchester County companies halting Medicaid ambulette transportation services, citing unfair reimbursementThe 10 companies under United Transportation Providers of Westchester County Inc. are stopping Medicaid transportation.
Källa: CBSNewYork - 🏆 268. / 63 Läs mer »